The investment will go toward finishing a Phase 2a clinical trial for an anti-infective to treat chronic infections in people with CF.
This year’s awardees showcase the diversity of journeys in the cystic fibrosis community.
|
5 min read
The investment will go toward finishing a Phase 2a clinical trial for an anti-infective to treat chronic infections in people with CF.
This year’s awardees showcase the diversity of journeys in the cystic fibrosis community.